MedPath

Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations

Not Applicable
Completed
Conditions
Venous Malformation
Interventions
Device: Electromagnetic Navigation
Registration Number
NCT04486599
Lead Sponsor
University Hospital, Toulouse
Brief Summary

The aim of this study is to evaluate the feasibility of assisted electromagnetic navigation in percutaneous echo-guided sclerotherapy of slow-flow vascular malformations. Feasibility will be defined in terms of the percentage of patients for whom the procedure is successful.

Detailed Description

Primary interventional treatment of low flow vascular anomalies includes ultrasound guided foam sclerotherapy. Each procedure involves a percutaneous needle insertion. However, procedures remain complicated to obtain the right trajectory in order to inject the foam at the center of the abnormality. Electromagnetic navigation system tracks the operator's needle, meaning the position and progression of the needle is visualized in 3D real time on the ultrasound probe interface.

The present trial evaluate the feasibility of the electromagnetic navigation system during the needle insertion and the improvement of needle placement accuracy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Low Flow Vascular Abnormality diagnosed by Duplex Ultrasound and MRI
  • Decision of Ultrasound Guided Percutaneous Foam Sclerotherapy taken in multidisciplinary staff meeting
Exclusion Criteria
  • patients with pacemakers or internal defibrillator
  • patients with ferromagnetic implanted material
  • patients who are wards of court or under guardianship
  • patients deprived of freedom by judicial or administrative decision
  • patients under legal protection
  • pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Electromagnetic NavigationElectromagnetic NavigationThe patient have to low Flow Vascular Abnormality diagnosed by Duplex Ultrasound and MRI. Decision of Ultrasound Guided Percutaneous Foam Sclerotherapy taken in multidisciplinary staff meeting
Primary Outcome Measures
NameTimeMethod
Percentage of patients for whom the procedure is successfulday 1

Success of procedure a.e. obtention of venous flow at the extremity of the needle permitting the realization of the foam sclerotherapy treatment.

Secondary Outcome Measures
NameTimeMethod
Estimate the time to complete catheterization of the malformationday 1

Duration of the procedure.

Estimate the number of punctures required to achieve catheterization of the malformation.day 1

Number of percutaneous punctures needed to obtain vascular backflow.

Estimate the undesirable effects associated with assisted electromagnetic navigation.day 1

Adverse effects of Electro-Magnetic Navigation.

Trial Locations

Locations (1)

University Hospital

🇫🇷

Toulouse, Occitanie, France

© Copyright 2025. All Rights Reserved by MedPath